Review



reference mouse anti bmp9  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems reference mouse anti bmp9
    Reference Mouse Anti Bmp9, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reference mouse anti bmp9/product/R&D Systems
    Average 93 stars, based on 22 article reviews
    reference mouse anti bmp9 - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems reference mouse anti bmp9
    Reference Mouse Anti Bmp9, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reference mouse anti bmp9/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    reference mouse anti bmp9 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    99
    R&D Systems reference mouse anti bmp9 ab
    ( A–D ) ELISAs were performed to measure IgG2a ( A , C ) and <t>anti-BMP9</t> Ab ( B , D ) levels in the serum of P6 neonates treated at P3 with vehicle (PBS), isotype control IgGs (IgG2a/2b), or anti-BMP9/10 Abs. Neonates were treated during lactation either from dams injected i.p. with ( A , B ), or by direct i.p. injections of ( C , D ), the different Abs or vehicle. Data represent mean ± s.e.m. (n = 5–7 pups per group from 2 dams); **** P < 0.0001, ANOVA.
    Reference Mouse Anti Bmp9 Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reference mouse anti bmp9 ab/product/R&D Systems
    Average 99 stars, based on 1 article reviews
    reference mouse anti bmp9 ab - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    R&D Systems reference mouse anti bmp9 antibody
    (A-C) ELISAs were performed to measure IgG2a (A), IgG2b (B), and <t>anti-BMP9</t> Ab (C) levels in the serum of P6 neonates breastfed by dams injected i.p. on P3 with either vehicle (PBS), isotype control IgGs (IgG2a/2b), or anti-BMP9/10 Abs. Data represents mean ± s.e.m. **** P < 0.0001, ANOVA.
    Reference Mouse Anti Bmp9 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/reference mouse anti bmp9 antibody/product/R&D Systems
    Average 99 stars, based on 1 article reviews
    reference mouse anti bmp9 antibody - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    ( A–D ) ELISAs were performed to measure IgG2a ( A , C ) and anti-BMP9 Ab ( B , D ) levels in the serum of P6 neonates treated at P3 with vehicle (PBS), isotype control IgGs (IgG2a/2b), or anti-BMP9/10 Abs. Neonates were treated during lactation either from dams injected i.p. with ( A , B ), or by direct i.p. injections of ( C , D ), the different Abs or vehicle. Data represent mean ± s.e.m. (n = 5–7 pups per group from 2 dams); **** P < 0.0001, ANOVA.

    Journal: Scientific Reports

    Article Title: A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10

    doi: 10.1038/srep37366

    Figure Lengend Snippet: ( A–D ) ELISAs were performed to measure IgG2a ( A , C ) and anti-BMP9 Ab ( B , D ) levels in the serum of P6 neonates treated at P3 with vehicle (PBS), isotype control IgGs (IgG2a/2b), or anti-BMP9/10 Abs. Neonates were treated during lactation either from dams injected i.p. with ( A , B ), or by direct i.p. injections of ( C , D ), the different Abs or vehicle. Data represent mean ± s.e.m. (n = 5–7 pups per group from 2 dams); **** P < 0.0001, ANOVA.

    Article Snippet: After washing 3 times with PBST, serial dilutions of individual mouse serum samples and reference mouse anti-BMP9 Ab (MAB3209, R&D Systems) (diluted in 1% BSA PBS) were prepared and 100 μL/well were incubated for 2 h at RT.

    Techniques: Control, Injection

    ( A – C ”) Representative images of fluorescent isolectin B4-stained retinas either from P6 neonates fed for 3 days by dams injected on P3 with PBS ( A ), control IgG2a/b Abs ( B ), or BMP9/10 blocking Abs ( C – C ”). ( C’ , C” ) are higher magnification images of the relevant boxed areas in C. a, artery; v, vein; scale bars, 500 μm. ( D–L ) Higher magnification showing retinal vasculature fields between an artery and a vein (Plexus, D–F ), or at the front of an artery ( G–I ) or a vein ( J–L ) from neonates treated as in ( A–C ). Scale bars, 100 μm. ( M–O ) Scatter plots showing the vascular density on retinal ‘petals’ at the plexus ( M ), artery front ( N ), or vein front ( O ). Data represent mean ± s.e.m. (n = 6 pups per group from 2 dams); **** P < 0.0001, ANOVA and Kruskal-Wallis test. Arrows indicate AVMs, defined as direct shunts between an artery and a vein.

    Journal: Scientific Reports

    Article Title: A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10

    doi: 10.1038/srep37366

    Figure Lengend Snippet: ( A – C ”) Representative images of fluorescent isolectin B4-stained retinas either from P6 neonates fed for 3 days by dams injected on P3 with PBS ( A ), control IgG2a/b Abs ( B ), or BMP9/10 blocking Abs ( C – C ”). ( C’ , C” ) are higher magnification images of the relevant boxed areas in C. a, artery; v, vein; scale bars, 500 μm. ( D–L ) Higher magnification showing retinal vasculature fields between an artery and a vein (Plexus, D–F ), or at the front of an artery ( G–I ) or a vein ( J–L ) from neonates treated as in ( A–C ). Scale bars, 100 μm. ( M–O ) Scatter plots showing the vascular density on retinal ‘petals’ at the plexus ( M ), artery front ( N ), or vein front ( O ). Data represent mean ± s.e.m. (n = 6 pups per group from 2 dams); **** P < 0.0001, ANOVA and Kruskal-Wallis test. Arrows indicate AVMs, defined as direct shunts between an artery and a vein.

    Article Snippet: After washing 3 times with PBST, serial dilutions of individual mouse serum samples and reference mouse anti-BMP9 Ab (MAB3209, R&D Systems) (diluted in 1% BSA PBS) were prepared and 100 μL/well were incubated for 2 h at RT.

    Techniques: Staining, Injection, Control, Blocking Assay

    ( A,B ) Representative images of blue latex-perfused retinal vasculature of P6 neonates fed for 3 days by dams injected on P3 with control IgG2a/b Abs ( A ) or BMP9/10 blocking Abs ( B ). Arrows in B indicate AVMs. Scale bars, 500 μm. ( C ) Scheme depicting the method employed for the quantification of the number of latex dye-positive vessels. ( D ) Histogram showing the total number of vascular crosses. ( E ) Histogram showing the number of vascular crosses per concentric circle on circles 1 to 3. Data represent mean ± s.e.m. (n = 5–7 pups per group from 2 dams); **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05; ANOVA and Kruskal-Wallis test ( D , E ).

    Journal: Scientific Reports

    Article Title: A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10

    doi: 10.1038/srep37366

    Figure Lengend Snippet: ( A,B ) Representative images of blue latex-perfused retinal vasculature of P6 neonates fed for 3 days by dams injected on P3 with control IgG2a/b Abs ( A ) or BMP9/10 blocking Abs ( B ). Arrows in B indicate AVMs. Scale bars, 500 μm. ( C ) Scheme depicting the method employed for the quantification of the number of latex dye-positive vessels. ( D ) Histogram showing the total number of vascular crosses. ( E ) Histogram showing the number of vascular crosses per concentric circle on circles 1 to 3. Data represent mean ± s.e.m. (n = 5–7 pups per group from 2 dams); **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05; ANOVA and Kruskal-Wallis test ( D , E ).

    Article Snippet: After washing 3 times with PBST, serial dilutions of individual mouse serum samples and reference mouse anti-BMP9 Ab (MAB3209, R&D Systems) (diluted in 1% BSA PBS) were prepared and 100 μL/well were incubated for 2 h at RT.

    Techniques: Injection, Control, Blocking Assay

    ( A ) RNA-Seq heat map displaying differently expressed genes in mouse whole retinas following transmammary transfer of anti-BMP9/10 or control IgG2a/2b Abs (n = 6 pups per group from 1 dam). ( B ) HUVECs were treated or not (Ctrl) with ALK1-Fc (1 μg/mL, 24 h). Cell extracts were then analyzed by WB using Abs directed against the indicated proteins. ( C ) Densitometric analyses and quantification of phospho-Smad1/5/8, ID1, and ANG2 relative levels in three independent experiments as in ( B ). ( D ) ECs isolated from retinas of pups fed for 3 days by dams injected on P3 with control IgG2a/b Abs (Ctrl) or BMP9/10 blocking Abs (anti-BMP9/10) were analyzed for Id1 and Angpt2 mRNA levels by RT-qPCR. The results are expressed as relative levels of the control condition (n = 3 determinations, n = 6 pups per group from 1 dam). Data in ( C , D ) are mean ± s.e.m.; *** P < 0.001, ** P < 0.01, * P < 0.05, unpaired Student’s t-test.

    Journal: Scientific Reports

    Article Title: A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10

    doi: 10.1038/srep37366

    Figure Lengend Snippet: ( A ) RNA-Seq heat map displaying differently expressed genes in mouse whole retinas following transmammary transfer of anti-BMP9/10 or control IgG2a/2b Abs (n = 6 pups per group from 1 dam). ( B ) HUVECs were treated or not (Ctrl) with ALK1-Fc (1 μg/mL, 24 h). Cell extracts were then analyzed by WB using Abs directed against the indicated proteins. ( C ) Densitometric analyses and quantification of phospho-Smad1/5/8, ID1, and ANG2 relative levels in three independent experiments as in ( B ). ( D ) ECs isolated from retinas of pups fed for 3 days by dams injected on P3 with control IgG2a/b Abs (Ctrl) or BMP9/10 blocking Abs (anti-BMP9/10) were analyzed for Id1 and Angpt2 mRNA levels by RT-qPCR. The results are expressed as relative levels of the control condition (n = 3 determinations, n = 6 pups per group from 1 dam). Data in ( C , D ) are mean ± s.e.m.; *** P < 0.001, ** P < 0.01, * P < 0.05, unpaired Student’s t-test.

    Article Snippet: After washing 3 times with PBST, serial dilutions of individual mouse serum samples and reference mouse anti-BMP9 Ab (MAB3209, R&D Systems) (diluted in 1% BSA PBS) were prepared and 100 μL/well were incubated for 2 h at RT.

    Techniques: RNA Sequencing, Control, Isolation, Injection, Blocking Assay, Quantitative RT-PCR

    Top 25 retinal genes sorted by P -value, following transmammary-delivered immunoblocking of  BMP9  and BMP10.

    Journal: Scientific Reports

    Article Title: A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10

    doi: 10.1038/srep37366

    Figure Lengend Snippet: Top 25 retinal genes sorted by P -value, following transmammary-delivered immunoblocking of BMP9 and BMP10.

    Article Snippet: After washing 3 times with PBST, serial dilutions of individual mouse serum samples and reference mouse anti-BMP9 Ab (MAB3209, R&D Systems) (diluted in 1% BSA PBS) were prepared and 100 μL/well were incubated for 2 h at RT.

    Techniques: Sterility, Binding Assay, Sequencing

    (A-C) ELISAs were performed to measure IgG2a (A), IgG2b (B), and anti-BMP9 Ab (C) levels in the serum of P6 neonates breastfed by dams injected i.p. on P3 with either vehicle (PBS), isotype control IgGs (IgG2a/2b), or anti-BMP9/10 Abs. Data represents mean ± s.e.m. **** P < 0.0001, ANOVA.

    Journal: bioRxiv

    Article Title: A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10

    doi: 10.1101/084889

    Figure Lengend Snippet: (A-C) ELISAs were performed to measure IgG2a (A), IgG2b (B), and anti-BMP9 Ab (C) levels in the serum of P6 neonates breastfed by dams injected i.p. on P3 with either vehicle (PBS), isotype control IgGs (IgG2a/2b), or anti-BMP9/10 Abs. Data represents mean ± s.e.m. **** P < 0.0001, ANOVA.

    Article Snippet: After washing 3 times with PBST, serial dilutions of individual mouse serum samples and reference mouse anti-BMP9 antibody (MAB3209, R&D Systems) (diluted in 1% BSA PBS) were prepared and 100 μL/well were incubated for 2 h at RT.

    Techniques: Injection, Control

    (A-C) Representative images of P6 fluorescent isolectin B4-stained retinas from neonate breastfed for 3 days by dams injected on P3 with PBS (A), control IgG2a/b Abs (B), or BMP9/10 blocking Abs (C). A, artery; V, vein; Scale bars, 500 μm. (D-L) Higher magnification showing retinal vasculature fields between an artery and a vein (Plexus, D-F), or at the front of an artery (G-I) or a vein (J-L). Scale bars, 100 μm. (M-O) Scatter plots showing the vascular density (n = 6 mice) between arteries and veins (M), or at the artery front (N) or vein front (O). Data represent mean ± s.e.m. **** P < 0.0001, ANOVA and Kruskal-Wallis test (M-O). Arrows in C and F indicate AVMs, defined as direct shunts between an artery and a vein.

    Journal: bioRxiv

    Article Title: A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10

    doi: 10.1101/084889

    Figure Lengend Snippet: (A-C) Representative images of P6 fluorescent isolectin B4-stained retinas from neonate breastfed for 3 days by dams injected on P3 with PBS (A), control IgG2a/b Abs (B), or BMP9/10 blocking Abs (C). A, artery; V, vein; Scale bars, 500 μm. (D-L) Higher magnification showing retinal vasculature fields between an artery and a vein (Plexus, D-F), or at the front of an artery (G-I) or a vein (J-L). Scale bars, 100 μm. (M-O) Scatter plots showing the vascular density (n = 6 mice) between arteries and veins (M), or at the artery front (N) or vein front (O). Data represent mean ± s.e.m. **** P < 0.0001, ANOVA and Kruskal-Wallis test (M-O). Arrows in C and F indicate AVMs, defined as direct shunts between an artery and a vein.

    Article Snippet: After washing 3 times with PBST, serial dilutions of individual mouse serum samples and reference mouse anti-BMP9 antibody (MAB3209, R&D Systems) (diluted in 1% BSA PBS) were prepared and 100 μL/well were incubated for 2 h at RT.

    Techniques: Staining, Injection, Control, Blocking Assay

    (A-B) Representative images of blue latex-perfused retinal vasculature of P6 neonate breastfed for 3 days by dams injected on P3 with control IgG2a/b Abs (A) or BMP9/10 blocking Abs (B). Arrows in B indicate AVMs. Scale bars, 500 μm. (C) Scheme depicting the method employed for the quantification of the number of latex dye-positive vessels. (D) Histogram showing the total number of vascular crosses. (E) Histogram showing the number of vascular crosses per concentric circle (Control, n = 5; IgG2a/b, n = 7; anti-BMP9/10 Abs, n = 6 mice). Data represents mean ± s.e.m.; **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05; ANOVA and Kruskal-Wallis test (D and E).

    Journal: bioRxiv

    Article Title: A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10

    doi: 10.1101/084889

    Figure Lengend Snippet: (A-B) Representative images of blue latex-perfused retinal vasculature of P6 neonate breastfed for 3 days by dams injected on P3 with control IgG2a/b Abs (A) or BMP9/10 blocking Abs (B). Arrows in B indicate AVMs. Scale bars, 500 μm. (C) Scheme depicting the method employed for the quantification of the number of latex dye-positive vessels. (D) Histogram showing the total number of vascular crosses. (E) Histogram showing the number of vascular crosses per concentric circle (Control, n = 5; IgG2a/b, n = 7; anti-BMP9/10 Abs, n = 6 mice). Data represents mean ± s.e.m.; **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05; ANOVA and Kruskal-Wallis test (D and E).

    Article Snippet: After washing 3 times with PBST, serial dilutions of individual mouse serum samples and reference mouse anti-BMP9 antibody (MAB3209, R&D Systems) (diluted in 1% BSA PBS) were prepared and 100 μL/well were incubated for 2 h at RT.

    Techniques: Injection, Control, Blocking Assay

    (A) Heat map displaying differently expressed genes in whole mouse retinas following transmammary transfer of anti-BMP9/10 or control IgG2a/2b Abs. (B) HUVECs were treated or not (Ctrl) with ALK1-Fc (1 μg/mL, 24 h). Cell extracts were then analyzed by WB using antibodies directed against the indicated proteins. (C) Densitometric analyses and quantification of phospho-Smad1/5/9, ID1, and Ang2 relative levels in three independent measurements as in (B). Results are mean ± s.e.m.; *** P < 0.001, ** P < 0.01 (unpaired Student’s t-test).

    Journal: bioRxiv

    Article Title: A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10

    doi: 10.1101/084889

    Figure Lengend Snippet: (A) Heat map displaying differently expressed genes in whole mouse retinas following transmammary transfer of anti-BMP9/10 or control IgG2a/2b Abs. (B) HUVECs were treated or not (Ctrl) with ALK1-Fc (1 μg/mL, 24 h). Cell extracts were then analyzed by WB using antibodies directed against the indicated proteins. (C) Densitometric analyses and quantification of phospho-Smad1/5/9, ID1, and Ang2 relative levels in three independent measurements as in (B). Results are mean ± s.e.m.; *** P < 0.001, ** P < 0.01 (unpaired Student’s t-test).

    Article Snippet: After washing 3 times with PBST, serial dilutions of individual mouse serum samples and reference mouse anti-BMP9 antibody (MAB3209, R&D Systems) (diluted in 1% BSA PBS) were prepared and 100 μL/well were incubated for 2 h at RT.

    Techniques: Control

    Journal: bioRxiv

    Article Title: A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10

    doi: 10.1101/084889

    Figure Lengend Snippet:

    Article Snippet: After washing 3 times with PBST, serial dilutions of individual mouse serum samples and reference mouse anti-BMP9 antibody (MAB3209, R&D Systems) (diluted in 1% BSA PBS) were prepared and 100 μL/well were incubated for 2 h at RT.

    Techniques: Gene Expression, Control, Expressing